Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Head & Neck 1Breast 1

Conditions

Prostatic Neoplasms 18Urinary Bladder Neoplasms 3Breast Neoplasms 2Recurrence 1Prostate Cancer Metastatic 1Parkinson Disease 1Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Disease 1Carcinoma, Transitional Cell 1

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Positron Emission Tomography Computed Tomography × Genitourinary × Clear all
NCT04018053 2026-01-27

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Brigham and Women's Hospital

Phase EARLY_PHASE1 Active not recruiting
16 enrolled 3 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04053101 2025-09-18

TEP-Vessie

Institut Bergonié

Completed
130 enrolled 4 charts
Genitourinary

Urinary Bladder Neoplasms

NCT01479348 2020-06-02

Imaging Study for FdCyd and THU Cancer Treatment

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
5 enrolled 12 charts
BreastGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡